Vivos Therapeutics, Inc.
VVOSNASDAQHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $2.36M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.12$3.11
- Volume (live)
- -
- Avg. volume (3M)
- 8.45M
Vivos Therapeutics (VVOS) Stock Price & Financial Analysis
Vivos Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.13 - $0.13 |
|---|---|
| 52-Week High | $3.11 |
| 52-Week Low | $0.12 |
| Open | $0.13 |
| Volume (last close) | 936.32K |
| Average Volume (3M) | 8.45M |
| Revenue (TTM) | 17.94M |
|---|---|
| Net Income (TTM) | -27.14M |
| Free Cash Flow (TTM) | -19.64M |
| EPS (TTM) | −$2.01 |
| Profit Margin | -151.27% |
| Operating Margin | -134.90% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 2.36M |
|---|---|
| Shares Outstanding | 17.68M |
| Price to Sales (P/S) | 0.13 |
| Price to Book (P/B) | -0.62 |
| EV/EBITDA | -0.36 |
| 50-Day MA | $0.19 |
|---|---|
| 200-Day MA | $0.83 |
| 1-Year Change | −95.54% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Vivos Therapeutics at a Glance
As of the Oct 23, 2026 close, Vivos Therapeutics (VVOS) has a market capitalization of $2.36M. The stock trades at 0.1× sales. Over the trailing twelve months it lost $27.14M on revenue of $17.94M and burned $19.64M of free cash flow. Revenue grew 3.6% year over year.
As of its latest reported balance sheet, it holds $1.77M in cash and securities against $8.14M of debt, a net debt position of $6.36M.
Vivos Therapeutics does not currently pay a dividend.
The share price is down 95.5% over the past year. At $0.13 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $0.12 to $3.10, below its 200-day moving average of $0.83.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About Vivos Therapeutics
What is the current stock price for VVOS?
As of the Oct 23, 2026 close, VVOS stock trades at $0.13. The 52-week range is $0.12–$3.11, with a day range of $0.13–$0.13.
What is the P/E ratio for VVOS?
The P/E ratio (Price-to-Earnings) for VVOS is shown in the Key Statistics section. This valuation metric helps compare Vivos Therapeutics, Inc. to industry peers.
Does VVOS pay dividends?
Vivos Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for VVOS?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for VVOS is Hold.
What is the market cap of VVOS?
As of the Oct 23, 2026 close, Vivos Therapeutics's market capitalization is $2.4M, classifying it as a micro-cap company. Vivos Therapeutics operates in the Healthcare sector within the Medical Devices industry.